CIK: 0001582844 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $153,941 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX INC | 2,635,287 | $23,981 | 15.6% | $5.04 | +40.8% | COM | 67576A100 |
| PRAX | PRAXIS PRECISION MEDICINES I | 162,302 | $9,904 | 6.4% | $18.01 | +149.1% | COM | 74006W207 |
| — | MERSANA THERAPEUTICS INC | 2,164,628 | $9,698 | 6.3% | $2.28 | — | COM | 59045L106 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,333,333 | $9,567 | 6.2% | $1.87 | +11.6% | COM SHS | 877619106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 326,787 | $8,804 | 5.7% | $18.58 | +52.9% | COM | 77313F106 |
| SRPT | SAREPTA THERAPEUTICS INC | 64,162 | $8,306 | 5.4% | $99.68 | +22.9% | COM | 803607100 |
| PCVX | VAXCYTE INC | 104,830 | $7,161 | 4.7% | $31.29 | +121.3% | COM | 92243G108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 396,099 | $6,967 | 4.5% | $16.47 | -6.8% | COM | 29337E102 |
| — | TOURMALINE BIO INC | 261,108 | $5,979 | 3.9% | $25.81 | — | COM | 89157D105 |
| — | APPLIED THERAPEUTICS INC | 792,000 | $5,386 | 3.5% | $4.51 | — | COM | 03828A101 |
| DYN | DYNE THERAPEUTICS INC | 184,500 | $5,238 | 3.4% | $13.53 | +67.1% | COM | 26818M108 |
| IRON | DISC MEDICINE INC | 76,800 | $4,782 | 3.1% | $35.48 | +82.7% | COM | 254604101 |
| RVMD | REVOLUTION MEDICINES INC | 143,777 | $4,634 | 3.0% | $24.03 | +23.3% | COM | 76155X100 |
| CLDX | CELLDEX THERAPEUTICS INC | 109,000 | $4,575 | 3.0% | $20.94 | +96.1% | COM NEW | 15117B202 |
| WHWK | AADI BIOSCIENCES INC | 1,849,402 | $4,328 | 2.8% | $27.48 | -93.0% | COM | 00032Q104 |
| — | HILLEVAX INC | 250,609 | $4,168 | 2.7% | $14.60 | — | COM | 43157M102 |
| CRNX | CRINETICS PHARMACEUTICALS | 78,403 | $3,670 | 2.4% | $20.61 | +89.9% | COM | 22663K107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 199,433 | $3,492 | 2.3% | $19.02 | +1.9% | COM | 92790C104 |
| TERN | TERNS PHARMACEUTICALS INC | 465,079 | $3,051 | 2.0% | $5.72 | +14.2% | COM | 880881107 |
| IMVT | IMMUNOVANT INC | 92,346 | $2,984 | 1.9% | $18.65 | +95.6% | COM | 45258J102 |
| VSTM | VERASTEM INC | 207,095 | $2,444 | 1.6% | $6.94 | +66.5% | COM NEW | 92337C203 |
| ACLX | ARCELLX INC | 34,500 | $2,399 | 1.6% | $45.11 | +40.6% | COMMON STOCK | 03940C100 |
| KURA | KURA ONCOLOGY INC. | 90,000 | $1,920 | 1.2% | $14.15 | +37.4% | COM | 50127T109 |
| INSM | INSMED INC | 61,718 | $1,674 | 1.1% | $27.00 | +3.6% | COM PAR $.01 | 457669307 |
| AGIO | AGIOS PHARMA | 55,262 | $1,616 | 1.0% | $26.78 | 0.0% | COM | 00847X104 |
| ORIC | ORIC PHARMACEUTICALS INC | 103,992 | $1,430 | 0.9% | $11.88 | 0.0% | COM | 68622P109 |
| MREO | MEREO BIOPHARMA GROUP PLC | 397,884 | $1,313 | 0.9% | $3.30 | — | SPON ADS | 589492107 |
| — | LYRA THERAPEUTICS INC | 173,320 | $1,078 | 0.7% | $6.22 | — | COM | 55234L105 |
| CYPH | LEAP THERAPEUTICS INC | 354,166 | $942 | 0.6% | $2.32 | +28.9% | COM NEW | 52187K200 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 20,000 | $934 | 0.6% | $47.17 | 0.0% | COM | 90400D108 |
| — | INTRA-CELLULAR THERAPIES INC. | 13,300 | $920 | 0.6% | $69.20 | — | COM | 46116X101 |
| — | CELLECTAR BIOSCIENCES INC. | 143,500 | $571 | 0.4% | $2.74 | — | COM NEW | 15117F807 |
| — | NUVATION BIO | 90,832 | $27 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |